International Journal of Hematology and Oncology 2020, Vol 30, Num 4 Page(s): 191-196
Gemcitabine, Oxaliplatin and Paclitaxel (GemPOx) in Patients with Relapsed or Refractory Germ Cell Tumors After High Dose Chemotherapy, A Retrospective Single-Center Experience

Ramazan ACAR1, Ismail ERTURK1, Halil KIZILOZ2, Sezgin OKCELIK2, Birol YILDIZ1, Musa Baris AYKAN1, Gul Sema Yıldıran KESKIN1, Galip BUYUKTURAN3, Serkan AKIN4, Nuri KARADURMUS1

1University of Health Science, Gulhane Faculty of Medicine, Department of Medical Oncology, Ankara, TURKEY
2Nevsehir State Hospital, Deparment of Urology, Nevsehir, TURKEY
3University of Health Science, Gulhane Faculty of Medicine, Department of Gastroenterology, Ankara, TURKEY
4Hacettepe University, Faculty of Medicine, Department of Medical Oncology, Ankara, TURKEY